News
| 21.05.2010 | The definite molecular diagnosis in patients with muscular dystrophies often requires the assessment of muscular expression of multiple proteins in small amounts of muscle tissue. The sample material obtained in muscle biopsies is limited and the measurement of multiple proteins is often restricted to conventional, non-quantitative assays, i.e. immunohistochemistry and immunoblotting. Here, we demonstrate that reverse protein arrays are a novel and excellent material-saving method for the measurement and quantification of changes in protein expression between healthy and diseased muscle tissue as well as cultured primary myotubes. | | 06.04.2010 | Zeptosens, as a single source provider of reverse protein array systems, recommends the NanoPlotter for the spotting of picoliters of complex samples on ZeptoMARK chips.
Reproducible spotting of samples on ZeptoMARK chips is achieved with the NanoPlotter, which is available in different configurations to optimally fit customers’ applications. Highly accurate spotting with a variety of samples derived from cells, tissues, as well as body fluids using ZeptoMARK buffers is one of the hallmarks of the NanoPlotter.
See the new flyer for more detailed information. | | 18.12.2009 | The following new assays are available for the ZeptoMARK reverse protein arrays:
Bik, Capase 3, Caspase 7, Caspase 7 cleaved Asp198, Caspase 8, Caspase 8 cleaved Asp347, Caspase 9, Caspase 9 cleaved Asp330, Met, Met pTyr1234, Met pTyr1349, PARP and Puma
The full list with 241 assays is available for download in the download section.
| | 23.11.2009 | Zeptosens is pleased to announce the release of the new ZeptoVIEW 3 software. ZeptoVIEW 3 integrates the entire workflow of reverse array protein profiling studies: easily define your study, track your samples, analyze the data and export the results for further analysis. Find all the details in the new ZeptoVIEW 3 flyer. | | 12.08.2009 | 12 new assays are available for the ZeptoMARK reverse protein arrays:
Histone H4, Tau, Rb, FRS2-alpha pTyr436, PDK-1, PDK-1 pSer241, PTEN, PTEN pSer380 Thr382 Thr383, Tsc-2 (Tuberin), Tsc-2 pThr1462, beta-Catenin pSer45, beta-Catenin pSer45 Thr41.
The full list is available for download in the download section.
| | 16.07.2009 | The University Complutense in Madrid discovered how different types of Salmonella reprogram host cell signaling upon infection. Effects on p38, JNK, ERK, Akt, GSK-3beta, FKHR and many more were measured by using Zeptosens' reverse protein arrays. Read the full publication in Proteomics. | | 21.04.2009 | ZeptoMARK Reverse Arrays are the leading technology to screen compound efficacy at a cellular level for multiple pathways and downstream targets in a flexible and cost effective manner. Besides the targets of interest, corresponding stress and apoptosis pathway markers can be measured simultaneously, giving an indication not only of compound efficacy but also toxicity. See more in the latest issue of Proteomics - Clinical Applications: Tracing pathway activities with kinase inhibitors and reverse phase protein arrays.
|
Events
| | 21-24.09.2010 | Basel
Switzerland | MipTec, learn about the ZeptoMARK reverse protein arrays: the leading technology for signalome based cellular screens. Meet us at booth J03.
| | | 16-19.11.2010 | Berlin
Germany
| EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics: learn about the big impact of reverse protein arrays in translational research from Zeptosens and meet us at booth F22 |
We welcome the opportunity to meet with you at any of these events to discuss your individual requirements and how our products and services might facilitate your projects. Please contact us at
This email address is being protected from spam bots, you need Javascript enabled to view it
or call +41 61 726 81 81 to arrange a meeting, conference call, site visit or workshop participation.
|
